CA2039643A1 - Anti-wart composition - Google Patents

Anti-wart composition

Info

Publication number
CA2039643A1
CA2039643A1 CA 2039643 CA2039643A CA2039643A1 CA 2039643 A1 CA2039643 A1 CA 2039643A1 CA 2039643 CA2039643 CA 2039643 CA 2039643 A CA2039643 A CA 2039643A CA 2039643 A1 CA2039643 A1 CA 2039643A1
Authority
CA
Canada
Prior art keywords
composition
treatment
warts
anesthetic
wart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2039643
Other languages
French (fr)
Other versions
CA2039643C (en
Inventor
Karl F. Popp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Laboratories Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2039643A1 publication Critical patent/CA2039643A1/en
Application granted granted Critical
Publication of CA2039643C publication Critical patent/CA2039643C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention pertains to a composition for use in the treatment of warts. The composition is used in the treatment of warts caused by human papilloma virus or against molluscum contagiosum. The composition comprises one or more topical keratolytic agents, a local anesthetic, and a topically acceptable carrier for the keratolytic agent and the anesthetic.
CA 2039643 1990-05-07 1991-04-03 Anti-wart composition Expired - Fee Related CA2039643C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52037490A 1990-05-07 1990-05-07
US520,374 1990-05-07

Publications (2)

Publication Number Publication Date
CA2039643A1 true CA2039643A1 (en) 1991-11-08
CA2039643C CA2039643C (en) 2002-09-10

Family

ID=24072326

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2039643 Expired - Fee Related CA2039643C (en) 1990-05-07 1991-04-03 Anti-wart composition

Country Status (1)

Country Link
CA (1) CA2039643C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9145444B2 (en) 2007-11-02 2015-09-29 Ruprecht-Karls-Universität Heidelberg Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
ES2614779A1 (en) * 2015-12-01 2017-06-01 Universidad De Sevilla Composition for systematic chemical treatment of plantar wart

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9145444B2 (en) 2007-11-02 2015-09-29 Ruprecht-Karls-Universität Heidelberg Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
ES2614779A1 (en) * 2015-12-01 2017-06-01 Universidad De Sevilla Composition for systematic chemical treatment of plantar wart

Also Published As

Publication number Publication date
CA2039643C (en) 2002-09-10

Similar Documents

Publication Publication Date Title
RU93047799A (en) COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL
ATE113650T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SELECTED STRAINS OF LACTOBACILLUS.
CA2181172A1 (en) Storage-stable prostaglandin compositions
CA2251331A1 (en) Calcilytic compounds
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
KR920002144A (en) Inflammatory bowel disease prevention and treatment containing zinc L-carnosine salt or its complex as an active ingredient
CA2027608A1 (en) Hair revitalizing agent
DE69310602D1 (en) 3 ', 5'-Ditertbutyl-4'-hydroxyflavone, process for their preparation and pharmaceutical composition with antioxidant and antivasoconstriction activity
ES8608535A1 (en) Pharmaceutical composition.
DE58906031D1 (en) Topical pharmaceutical preparation.
AU674142B2 (en) Use of cosmetic composition
RU95101375A (en) N-(3-aminopropyl)-n-phenyl-5,6,7,8-tetrahydronaphthalene- 2-carboxamide derivatives, preparation and use thereof in therapy
CA2135614A1 (en) Use of urodilatin in pulmonary and bronchial diseases
EP0415766A3 (en) Use of retinoids for reversing glucocorticoid-induced skin atrophy
GB9125712D0 (en) Skin care composition
CA2132841A1 (en) Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
AU5686196A (en) Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses
CA2092979A1 (en) Cyclodextrin inclusion complex of paclitaxel, and method for its production and its use
IT1264856B1 (en) PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY
AU604418B2 (en) Cosmetic composition
CA2020017A1 (en) Novel composition and topical and systemic treatments of conditions caused by heavy, oily or greasy secretions
AU8687391A (en) Lithium treatment
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
CA2039643A1 (en) Anti-wart composition
EP0202673A3 (en) Titanocene complexes having a cytostatic activity

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed